Cargando…

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy

OBJECTIVES: We assessed the impact of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following administration of the 23-valent pneumococcal polysaccharide vaccine (PPV23). METHODS: A total of 190 patients with rheumatoid arthritis (RA) received P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Shunsuke, Ueki, Yukitaka, Akeda, Yukihiro, Hirakata, Naoyuki, Oribe, Motohiro, Shiohira, Yoshiki, Hidaka, Toshihiko, Oishi, Kazunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711492/ https://www.ncbi.nlm.nih.gov/pubmed/23345600 http://dx.doi.org/10.1136/annrheumdis-2012-202658

Ejemplares similares

Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
por: Mori, Shunsuke, et al.
Publicado: (2012)

Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
por: Mori, Shunsuke, et al.
Publicado: (2015)

Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study
por: Mori, Shunsuke, et al.
Publicado: (2019)

Global Control of Pneumococcal Infections by Pneumococcal Vaccines
por: Oishi, Kazunori, et al.
Publicado: (2014)

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals
por: Mori, Shunsuke, et al.
Publicado: (2017)

Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab
por: Mori, Shunsuke, et al.
Publicado: (2011)

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan
por: Mori, Shunsuke, et al.
Publicado: (2017)

Tofacitinib versus tocilizumab in the treatment of biological-naïve or previous biological-failure patients with methotrexate-refractory active rheumatoid arthritis
por: Mori, Shunsuke, et al.
Publicado: (2021)

Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases
por: Mori, Shunsuke, et al.
Publicado: (2016)

The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial
por: Izumi, Yasumori, et al.
Publicado: (2017)

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Mechanisms Underlying Pneumococcal Transmission and Factors Influencing Host-Pneumococcus Interaction: A Review
por: Morimura, Ayumi, et al.
Publicado: (2021)

Tofacitinib Therapy for Rheumatoid Arthritis: A Direct Comparison Study between Biologic-naïve and Experienced Patients
por: Mori, Shunsuke, et al.
Publicado: (2017)

Density and duration of experimental human pneumococcal carriage
por: Gritzfeld, J F, et al.
Publicado: (2014)

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
por: Shimbashi, Reiko, et al.
Publicado: (2020)

Whole-Genome Analysis-Based Phylogeographic Investigation of Streptococcus pneumoniae Serotype 19A Sequence Type 320 Isolates in Japan
por: Nakano, Satoshi, et al.
Publicado: (2022)

Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study
por: Mori, Shunsuke, et al.
Publicado: (2022)

Persisting high prevalence of pneumococcal carriage among HIV-infected adults receiving antiretroviral therapy in Malawi: a cohort study
por: Heinsbroek, Ellen, et al.
Publicado: (2015)

Pneumococcal infections and homelessness
por: LY, TRAN DUC ANH, et al.
Publicado: (2022)

The impact of pneumococcal vaccination on pneumonia mortality among the elderly in Japan: a difference-in-difference study
por: Jung, Sung-mok, et al.
Publicado: (2018)

Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi
por: Thindwa, Deus, et al.
Publicado: (2022)

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
por: Burmester, Gerd R, et al.
Publicado: (2016)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Origin of Circulating Free DNA in Sepsis: Analysis of the CLP Mouse Model
por: Hamaguchi, Shigeto, et al.
Publicado: (2015)

Fatal Septic Meningitis in Child Caused by Streptococcus suis Serotype 24
por: Kerdsin, Anusak, et al.
Publicado: (2016)

Genotypic Comparison between Streptococcus suis Isolated from Pigs and Humans in Thailand
por: Kerdsin, Anusak, et al.
Publicado: (2020)

Genomic differences between sequence types 1 and 104 of Streptococcus suis Serotype 2
por: Kerdsin, Anusak, et al.
Publicado: (2022)

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
por: Ramiro, Sofia, et al.
Publicado: (2020)

Dectin-2-Dependent NKT Cell Activation and Serotype-Specific Antibody Production in Mice Immunized with Pneumococcal Polysaccharide Vaccine
por: Miyasaka, Tomomitsu, et al.
Publicado: (2013)

Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis
por: Fortanier, Alexandre C, et al.
Publicado: (2018)

Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
por: Quirk, Sigríður J., et al.
Publicado: (2019)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA
por: Link-Gelles, Ruth, et al.
Publicado: (2017)

Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine
por: Lo, Stephanie W., et al.
Publicado: (2018)

Social capital and pneumococcal vaccination (PPSV23) in community-dwelling older Japanese: a JAGES multilevel cross-sectional study
por: Iwai-Saito, Kousuke, et al.
Publicado: (2021)

The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study
por: Iwamoto, Naoki, et al.
Publicado: (2022)

Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment
por: Mori, Shunsuke, et al.
Publicado: (2018)

Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
por: Mori, Shunsuke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s6dqct90ao682nfhdntrush9o6